177Lu-CTR-FAPI for the Treatment of Thyroid Cancer
NCT07438847
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Thyroid Cancer
Interventions
DRUG:
177Lu-CTR-FAPI therapy
Sponsor
SHAOYAN LIU
Collaborators
[object Object]
[object Object]
[object Object]